What is the FII and DII shareholding of GlaxoSmithKline Pharma?

Foreign Institutional Investors (FIIs) own 4.75%. Domestic Institutional Investors (DIIs) hold 2.41% of GlaxoSmithKline Pharma.

What is the retail shareholding of GlaxoSmithKline Pharma?

The retail shareholding of GlaxoSmithKline Pharma is 11.77%

The shareholding pattern of GlaxoSmithKline Pharma is updated quarterly as per SEBI regulations.

₹2,575.00₹2,575.00+₹43.60 (1.72%)

As on 03 Nov, 2026 | 15:29 IST

Shareholding Pattern

Promoters (75.00%)	Mutual funds (6.07%)	Retail and other (11.77%)
FII (4.75%)	Other DII (2.41%)

Promoters

Category	Sep 2026	Jun 2026	Mar 2026	Dec 2025
Promoters	75.00%	75.00%	75.00%	75.00%
FII	4.75%	4.79%	4.62%	4.64%
Other DII	2.41%	2.93%	2.95%	2.93%
Retail and other	11.77%	12.41%	12.69%	12.66%
Mutual funds	6.07%	4.87%	4.73%	4.77%

The promoters of GlaxoSmithKline Pharma currently hold 75% of the company’s total shares.